Wall Street analysts expect that National Health Investors Inc (NYSE:NHI) will announce $77.00 million in sales for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for National Health Investors’ earnings, with estimates ranging from $75.29 million to $78.10 million. National Health Investors reported sales of $72.96 million during the same quarter last year, which would suggest a positive year over year growth rate of 5.5%. The firm is scheduled to announce its next quarterly earnings report before the market opens on Thursday, August 8th.
According to Zacks, analysts expect that National Health Investors will report full year sales of $310.54 million for the current financial year, with estimates ranging from $303.64 million to $319.56 million. For the next year, analysts anticipate that the company will report sales of $331.23 million, with estimates ranging from $313.32 million to $350.66 million. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side analysts that follow National Health Investors.
National Health Investors (NYSE:NHI) last posted its quarterly earnings data on Tuesday, May 7th. The real estate investment trust reported $0.83 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.31 by ($0.48). The company had revenue of $76.11 million for the quarter, compared to analysts’ expectations of $73.21 million. National Health Investors had a net margin of 50.87% and a return on equity of 10.96%. The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the previous year, the business earned $1.35 earnings per share.
Several hedge funds and other institutional investors have recently modified their holdings of NHI. Marshall Wace North America L.P. acquired a new stake in shares of National Health Investors in the first quarter valued at about $31,000. Farmers National Bank acquired a new stake in shares of National Health Investors in the first quarter valued at about $49,000. Quadrant Capital Group LLC raised its position in shares of National Health Investors by 306.7% in the first quarter. Quadrant Capital Group LLC now owns 793 shares of the real estate investment trust’s stock valued at $61,000 after buying an additional 598 shares during the last quarter. Liberty Wealth Management LLC acquired a new stake in shares of National Health Investors in the fourth quarter valued at about $69,000. Finally, Brinker Capital Inc. acquired a new stake in shares of National Health Investors in the first quarter valued at about $202,000. Institutional investors and hedge funds own 69.98% of the company’s stock.
NHI traded up $0.17 during midday trading on Friday, hitting $80.01. 194,979 shares of the company traded hands, compared to its average volume of 168,994. The stock’s 50 day moving average price is $79.33. The stock has a market cap of $3.46 billion, a P/E ratio of 14.60, a price-to-earnings-growth ratio of 3.61 and a beta of 0.37. The company has a debt-to-equity ratio of 0.91, a current ratio of 14.99 and a quick ratio of 14.99. National Health Investors has a 52-week low of $70.54 and a 52-week high of $84.57.
The firm also recently announced a quarterly dividend, which will be paid on Friday, August 9th. Stockholders of record on Friday, June 28th will be given a $1.05 dividend. This represents a $4.20 dividend on an annualized basis and a dividend yield of 5.25%. The ex-dividend date of this dividend is Thursday, June 27th. National Health Investors’s dividend payout ratio (DPR) is 76.64%.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Read More: Sell-Side Analysts
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.